Toll-like receptor 2 (TLR2) Ab 25-35 -induced neuronal loss p-tau Synaptophysin Microglia Organotypic hippocampal slice cultures a b s t r a c t Toll-like receptors (TLRs), which have been implicated in various neuroinflammatory responses, are thought to act in defense mechanisms by inhibiting neuronal cell death in Alzheimer's disease. In this study, we evaluated the effects of TLR2 on amyloid beta peptide [25][26][27][28][29][30][31][32][33][34][35] )-induced neuronal cell death, synaptic dysfunction, and microglial activation in organotypic hippocampal slice cultures (OHSCs) from wild-type (WT) C57BL/6 mice and TLR2-knockout (KO) mice. In WT mice, Ab 25-35 induced b-amyloid aggregation and surrounding TLR2 expression. And, propidium iodide (PI) uptake, which is a measure of cell death, increased in a dose-dependent manner in slices with Ab 25-35 treatment. In the Ab 25-35 -treated TLR2-KO OHSCs, the PI uptake was significantly attenuated to the control level, indicating that the cells were less susceptible to Ab 25-35 -induced neuronal toxicity. In the ultrastructural analysis, nuclear shrinkage, slightly swollen mitochondria, and degraded organelles were detected in the Ab 25-35 -treated slices from WT mice but not in the Ab 25-35 -treated slices from TLR2-KO, suggesting the resistance of TLR2-KO to Ab 25-35 -induced neurotoxicity. In Ab 25-35 -treated OHSCs of WT mice, the levels of phosphorylated tau were increased and the levels of synaptophysin were decreased in a dose-dependent manner, but they were not changed in OHSCs of TLR2-KO mice. In WT mice, Ab 25-35 increased total protein level and immunoreactivity of Iba-1, which was colocalized with TLR2. However, there were no significant changes in the slices of Ab 25-35 -treated TLR2-KO mice. These results suggested that TLR2 may play a role in Ab 25-35 -induced neuronal cell loss and synaptic dysfunction through the activation of microglia in OHSCs.
Introduction
The disruption of neuronal cell connections results in synaptic loss and damage, which in turn leads to the characteristic symptoms of dementia (Gleichmann and Mattson, 2010; Selkoe, 2002) . The most common cause of dementia in the elderly is Alzheimer's disease (AD), which is clinically characterized by memory loss and cognitive dysfunction (Hardy and Selkoe, 2002) , and it is pathologically characterized by the loss of neurons, intracellular neurofibrillary tangles, and extracellular deposits of b amyloid plaques (Schrag et al., 2008; Selkoe and Schenk, 2003; Takahashi et al., 2010) . Although amyloid beta peptide (Ab) is well known as the main cause of neuronal cell death (Baskys and Adamchik, 2001; Cavallucci et al., 2012; Kreutz et al., 2011; Kudo et al., 2012; Suh et al., 2008) , the exact mechanism is not completely understood.
The deposition of Ab, particularly in the fibrillar form, is closely associated with inflammatory responses (Tahara et al., 2006; Udan et al., 2008) . Ab deposits activate microglia, the principal immune effector cells of the brain, and initiate a proinflammatory cascade that results in the release of potentially cytotoxic molecules, cytokines, and other related compounds (Liu et al., 2012; Neher et al., 2011; Richard et al., 2008) .
Toll-like receptors (TLRs) are a family of pattern recognition receptors and have functions in innate immune recognition. Activated TLRs lead to intracellular signal transduction cascades, which upregulate the expression of proinflammatory cytokines, chemokines, nitric oxide synthase, and other anti-microbial peptides that directly destroy microbial pathogens (Covacu et al., 2009; Han and Ulevitch, 2005) .
In neurons, TLRs act as neuroinflammatory receptors. They regulate immune responses through the activation of microglia when neurons are exposed to brain injury (Hoffmann et al., 2007; Hong et al., 2010; Vollmar et al., 2010) . Many subtypes of TLRs (TLR2, TLR3, TLR4, and TLR9) are detected in the central nervous system, including neurons, astrocytes, and microglia (Hamanaka and Hara, 2011; Hoffmann et al., 2007; Lafon et al., 2006; Lotz et al., 2005) .
The activation of TLR2 results in increased proinflammatory cytokines in response to various types of neuronal damage, including brain ischemia (Hamanaka and Hara, 2011; Lv et al., 2011; Ziegler et al., 2011) , Wallerian degeneration (Boivin et al., 2007) , multiple sclerosis (Hanafy and Sloane, 2011) , and spinal cord injury (Hoffmann et al., 2007; Kim et al., 2007) . The inhibition of TLR2 promotes neuronal survival in focal cerebral ischemia (Ziegler et al., 2011) , and kainic acid-induced neurotoxicity and microglial activation were compromised in TLR2-knockout (KO) mice (Hong et al., 2010) , suggesting TLR2's role in neurotoxicity. TLRs are also involved in the clearance of Ab deposits in AD conditions (Tahara et al., 2006) , and the infusion of Ab 1-42 into the hippocampus induced TLR2 expression (Richard et al., 2008) . Fibrillar Ab activates microglia through the TLR2 signaling pathway, which mediates the increased cellular uptake of Ab and has a pathophysiological significance (Jana et al., 2008) . Although there are many reports about Ab induced neurotoxicity, the role of TLR2 in Ab-induced neuronal cell death is still unclear.
Because TLR2 is expressed in other immune cells in vivo, it is still possible that the modification of Ab-induced neurotoxicity in TLR2-KO mice is due to TLR2 ablation in other immune cells, rather than microglia. Therefore, in this study, we investigated the roles of TLR2 through the microglial activation of Ab 25-35 -induced neurotoxicity in organotypic hippocampal slice cultures (OHSCs).
Materials and methods

Animals
TLR2-KO mice were generously donated by Dr. Sung Joong Lee. All surgical and experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Ewha Womans University.
Preparation of OHSCs
The OHSCs were prepared, as previously described (Jung et al., 2012; Suh et al., 2008) , from the hippocampus of 8-day-old TLR2-KO mice and C57BL/6 mice, which were used as the wild-type (WT) controls. They were dissected and cut at a 400-lm thickness with a McIlwain tissue chopper (The Mickle Laboratory Engineering Co., Ltd., Surrey, UK). The medium was changed twice weekly for 2 weeks.
Treatment of OHSCs with Ab 25-35
Ab 25-35 is shorter than Ab 1-42, but it is sufficient to cause neurotoxicity similar to Ab 1-42 (Chen et al., 2013; Frozza et al., 2009; Suh et al., 2008) . Ab 25-35 (Sigma-Aldrich Co., St. Louis, MO) was dissolved in sterile deionized water to give a stock solution with a concentration of 1 mM, and was then incubated at 37°C for 24 h in order to obtain the aggregated fibrillar form. The final concentrations (10, 25, and 50 lM) of the Ab 25-35 solutions were applied to culture medium for 72 h.
Thioflavin S (ThS) staining
To detect amyloid plaques, modified ThS staining (Lee et al., 2002) was performed in the OHSCs of WT mice. After fixation with 4% paraformaldehyde, the slices were stained with 0.5% thioflavin S (Sigma-Aldrich Co.) for 8 min in dark room and washed three times with 80% ethanol for 2 min, and washed twice with 95% ethanol for 3 min, and then washed with distilled water before blocking. The slices were mounted with vectashield including DAPI (Vector Lab. Inc., Burlingame, CA).
Measurement of propidium iodide (PI) uptake
The extent of cell death was assessed with the fluorescent exclusion dye PI. PI (2 lg/mL) was added to the culture medium and incubated in the dark for 2 h at 37°C. After washing with phosphate-buffered saline (PBS), images were obtained with an inverted fluorescence microscope (Zeiss Axiovert 200; Carl Zeiss Microscopy GmbH, Göttingen, Germany). The image intensity was analyzed using the AxioVision version 4.7.1.0 program (Imaging Solutions GmbH, Munich, Germany). For the quantifica- tion, a region of interest was selected from the bright-field images of each slice. Relative cell death was calculated as previously demonstrated (Jung et al., 2004; Suh et al., 2008 ).
Ultrastructural analysis with transmission electron microscopy
The slices were fixed with 2.5% glutaraldehyde and 2% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The slices were postfixed in 1% osmium tetroxide, dehydrated gradually in ethanol, and embedded with Epon 812. Semithin sections (100 nm) were cut from tissue blocks and stained with 0.5% toluidine blue. The most superficial stratum lucidum and mossy fiber layers were identified by the meningeal tissue for subsequent thin sectioning. The ultrathin sections were stained with 0.25% lead citrate and 2% uranyl acetate in 50% methanol and observed with an electron microscope (Hitachi H7650; Hitachi High-Technologies Corporation, Tokyo, Japan).
Protein extraction and Western blot analysis
The slices were lysed in 50 lL of ice-cold lysis buffer (50 mM Tris-HCl, 1% IGEPAL, 0.25% deoxycholic acid, 150 mM NaCl, 1 mM ethylene glycol tetraacetic acid, and 1 mM NaF) with a protease inhibitor (Roche Diagnostics GmbH, Penzberg, Germany) and were briefly sonicated. Samples were boiled for 5 min, and 20 lg of protein was electrophoresed on a 12% sodium dodecyl sulfate-polyacrylamide gel. The proteins were transferred onto blotting membranes (0.45 mm, polyvinylidene difluoride, Millipore, Billerica, MA). The membranes were blocked for 1 h with Tris-buffered saline Tween (TBST; 20 nM Tris, 500 nM NaCl, and 0.05% Tween 20) containing 10% skim milk and were probed overnight at 4°C with anti-TLR2 (rabbit polyclonal IgG, 1:500; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), anti-p-tau(Ser262) (rabbit polyclonal IgG, 1:200; Santa Cruz Biotechnology, Inc.), anti-synaptophysin (mouse monoclonal IgG 1 , 1:1,000; Millipore, Billerica, MA), or anti-Iba1 (rabbit polyclonal, 1:500; Wako Pure Chemical Industries, Ltd., Osaka, Japan). Immunoreactive bands were visualized with a luminescent image analyzer (LAS 3000 imaging system; Fujifilm Corporation, Tokyo, Japan) using a chemiluminescence reagent (Santa Cruz Biotechnology, Inc.). Densitometric data were obtained with the Multi Gauge version 3.0 image analysis software (Fujifilm Corporation, Tokyo, Japan). For a loading control, membranes were stripped and reprobed with an anti-actin antibody (1:1,000; Santa Cruz Biotechnology, Inc.). Total protein levels for p-tau (Ser262), TLR2, Iba-1, or synaptophysin were measured in the aliquots from the same slice sample and were normalized to actin.
Immunofluorescence staining
The slices were fixed for 24 h with 4% paraformaldehyde (Merck, Darmstadt, Germany) in 0.1 M phosphate buffer and then incubated at room temperature for 1 h in blocking solution containing 0.2% Triton X-100 in 10% bovine serum albumin in PBS. The slices were incubated for 24 h at 4°C with anti-b-amyloid (mouse monoclonal IgG 1 , 1:500; Santa Cruz Biotechnology, Inc.), anti-TLR2 (mouse monoclonal IgG2a, 1:500; eBioscience), anti-TLR2 (rabbit polyclonal IgG, 1:500; Santa Cruz Biotechnology, nc.), anti-NeuN (mouse monoclonal IgG 1 , 1:1,000; Millipore), anti-p-tau (Ser262) (rabbit polyclonal IgG, 1:200; Santa Cruz Biotechnology, Inc.), or anti-Iba1 (rabbit polyclonal, 1:500; Wako Pure Chemical Industries, Ltd.). After 3 washes with 3% bovine serum albumin in PBS, anti-rabbit or anti-mouse secondary antibodies that were conjugated to Alexa fluor 488 goat anti-rabbit IgG (1:1,000; Life Technologies, Grand Island, NY) or Alexa fluor 555 goat anti-mouse IgG (1:1,000; Life Technologies) were applied. The slices were mounted with Elvanol mounting medium (Waterborne, Inc., New Orleans, LA), and images were obtained with a confocal microscope (Zeiss LSM 510; Carl Zeiss Microscopy GmbH, Jena, Germany).
Data analysis
The results are represented as the mean ± standard error of the mean (SEM). The data were analyzed with analysis of variance (AN-OVA) tests using Statview version 5 software (SAS Institute, Inc., Cary, NC). A Fisher's post hoc test was used to determine the means that were significantly different from the control mean. p values that were less than 0.05 were considered to be statistically significant.
Results
Ab 25-35 increased b-amyloid aggregation and TLR2 in the OHSCs of WT mice
To confirm Ab 25-35 -induced neurotoxicity model, ThS staining or immunofluorescence staining for b-amyloid were performed. After Ab 25-35 -treatment to the OHSCs of WT mice, amyloid plaques stained with ThS and b-amyloid aggregation were remarkably increased, indicating Ab 25-35 -induced neurotoxicity model (Fig. 1A  & B) .
Since the deposition of b-amyloid aggregation in AD is related to neuroinflammatory response such as TLRs (Chen et al., 2006; Bolmont et al., 2008; Reed-Geaghan et al., 2010) , the relationship between TLR2 activation and deposition of b-amyloid in Ab 25-35 -induced neurotoxicity model was evaluated. The total protein level and immunofluorescence for TLR2 after treatment of Ab 25-35 were significantly increased (Fig. 1B & C) , and TLR2 expression was usually found near b-amyloid aggregation (Fig. 1B) , suggesting Ab 25-35 -induced local neuroinflammation.
Ab 25-35 -induced neuronal cell death was reduced in the OHSCs of TLR2-KO mice
To examine the effect of TLR2 on the Ab 25-35 -induced neuronal toxicity, PI uptake was analyzed quantitatively. Without Ab 25-35 , cells with PI uptake were hardly observed in the cultured hippocampal slices from both WT and TLR2-KO mice ( Fig. 2A) . WT OHSCs that received Ab 25-35 treatment for 3 days had significantly increased PI intensity that was concentration-dependent (10, 25, and 50 lM; Fig. 2A ) in both CA1 (37.24 ± 8.34, 42.34 ± 8.34, and 52.20 ± 8.07, respectively; Fig. 2B) and CA3 (15.20 ± 13.15, 33 .14 ± 6.1, and 33.04 ± 6.77, respectively; Fig. 2C ) areas. In the Ab 25-35 -treated TLR2-KO OHSCs, the PI uptake was significantly attenuated to the control level (Fig. 2) , indicating that neurons in OHSCs from TLR2-KO mice are less susceptible to Ab 25-35 -induced neuronal toxicity.
3.3. Ab 25-35 -induced changes in ultrastructure were less vulnerable in the OHSCs of TLR2-KO mice
In the control OHSCs from both WT and TLR2-KO mice, the nuclei were clearly observed, mitochondria were abundant, and other organelles were well distributed. Microtubules in the axons were densely packed and had parallel arrangements. No significant differences were observed between WT and TLR2-KO. In the Ab 25-35 -treated OHSCs from WT mice, the nucleus has shrunk, the plasma membrane continuity was lost, and numerous vacuolations in the cytoplasm were observed. Mitochondria were slightly swollen and abnormally developed. Microtubules showed widened intervals and unparallel arrangements. In the Ab 25-35 -treated OHSC from TLR2-KO mice, the nucleus and other organelles, including mitochondria, rough endoplasmic reticulum, and microtubules, appeared quite normal (Fig. 3) . Ultrastructural changes were not specifically detected, suggesting the resistance of TLR2-KO to Ab 25-35 -induced neurotoxicity.
Ab 25-35 -induced expression of phosphorylated tau was not increased in the OHSCs of TLR2-KO mice
The hyperphosphorylation of tau is known to be involved in impaired neuronal function in AD (Johansson et al., 2006; Metcalfe and Figueiredo-Pereira, 2010; Obulesu et al., 2011) . To clarify the relationship among Ab 25-35 -induced neuronal cell death, the phosphorylation of tau, and TLR2, western blot analysis of p-tau (Ser 262) was performed. The total protein level of phosphorylated tau was increased in a dose-dependent manner (10, 25, and 50 lM)
in Ab 25-35 -treated OHSCs of WT mice (112.71 ± 11.93, 135.21 ± 2.72, and 150.16 ± 10.04, respectively), but they were not changed in the OHSCs of TLR2-KO mice (Fig. 4A) .
In immunofluorescence analysis for the OHSCs of WT mice, Ab 25-35 induced the hyperphosphorylation of tau mostly in damaged neurons which expressed less NeuN immunoreactivity (Fig. 4B). 3.5. Ab 25-35 -induced reduction of synaptophysin was not found in OHSCs of TLR2-KO mice
To determine the role of TLR2 in Ab 25-35 -induced synaptic failure, western blot analysis of synaptophysin was used. The levels of synaptophysin were decreased in a dose-dependent manner (10, 25, and 50 lM) in Ab 25-35 -treated OHSCs of WT mice (84.24 ± 7.89, 73.29 ± 11.74, and 61.55 ± 9.46, respectively). In contrast, the levels of synaptophysin were not decreased in OHSCs of TLR2-KO mice (Fig. 5) .
Ab 25-35 -induced microglial activation was reduced in the OHSCs of TLR2-KO mice
In order to investigate the role of TLR2 in the microglial activation that is induced by Ab 25-35 , we performed western blot analysis and immunofluorescence staining for Iba-1. The total protein level of Iba-1 in the OHSCs of WT mice was significantly increased after treatment with 25 lM Ab 25-35 (140 ± 10.83). There were no differences in the protein levels of Iba-1 between control and Ab 25-35 -treated TLR2-KO mice (Fig. 6B) .
In the OHSCs from WT mice, the number of Iba-1-positive microglia is increased in a dose-dependent manner (10, 25, and 50 lM) in the Ab [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] 22.35 ± 0.65, and 29.93 ± 0.99, respectively) compared to WT (14.23 ± 2.53). The morphology of Iba-1-positive cells in OHSCs of WT mice showed thicker and longer processes with Ab 25-35 treatment, suggesting activation, and this response was dosedependent (Fig. 6A) . These increased Iba-1 immunoreactivity by Ab 25-35 treatment in OHSCs of WT mice was colocalized with TLR2 (Fig. 6C) . The Ab 25-35 -induced Iba-1 activation was significantly decreased in OHSCs of TLR2-KO mice compared to that of WT mice according to the quantification of the immunoreactivity of Iba-1 (Fig. 6A ).
Discussion
In this study, we demonstrated that TLR2 contributes to Ab 25-35 -induced hippocampal neuronal cell death. It is well known that Ab 25-35 can induce neurotoxicity in various cellular events, including apoptotic or necrotic cell death (Ishige et al., 2007; Kreutz et al., 2011; Suh et al., 2008) . Fig. 1 showed that amyloid aggregates were present in CA3 area after Ab 25-35 treatment in OHSCs of WT mice, suggesting that a short 25-35 of bamyloid is sufficient to cause Ab effects. Additionally, there are many previous studies that have demonstrated the involvement of neuroinflammation in AD, including proinflammatory mediators (Akiyama et al., 2000) , microglial activation surrounding Ab plaques (Bolmont et al., 2008; Bornemann et al., 2001) , and increased TLR expression (Fassbender et al., 2004; Letiembre et al., 2007; Walter et al., 2007) . Fig. 1 also showed that TLR2 expression was increased surrounding b-amyloid aggregation, suggesting Ab 25-35 -induced neuroinflammation. However, the role of TLR2 in Ab-induced neuronal cell death is still unclear. Because TLR2 is highly expressed in other immune cells of the whole body, it is still possible that the effect of TLR2 KO is due to immune cells other than microglia. Therefore, we chose an ex vivo AD model using the OHSCs of TLR2-KO mice.
Our findings show that increased PI uptake, ultrastructural damages including mitochondrial abnormality, and hyperphosphorylation of tau in the damaged neurons after Ab 25-35 treatment are significantly attenuated in the OHSCs of TLR2-KO mice compared to controls. Ab can cause mitochondrial dysfunction (Hardy and Selkoe, 2002; Johansson et al., 2006; Obulesu et al., 2011; Rapoport et al., 2002; Reddy, 2011) and hyperphosphorylation and aggregation of tau (Johansson et al., 2006; Obulesu et al., 2011; Ott et al., 2011; Reddy, 2011; Schrag et al., 2008) in neurons with neurite degeneration and microtubule disintegration. On the basis of these results, we suggest that the hyperphosphorylation of tau may be related to increase of TLR2 during Ab 25-35 -induced neurotoxicity.
Although a number of studies that focused on the synaptic impairment in AD have been reported, the current understanding is not sufficient to explain the relationship among Ab, TLR2, and synaptic function. Ab accumulation reduced the synapse density of cortical and hippocampal neurons (Selkoe, 2002) , and the expression of presynaptic proteins was decreased by Ab 25-35 -induced hippocampal neuronal cell death (Costello et al., 2011; Suh et al., 2008) . In this study, the level of synaptophysin, which is a marker of a presynaptic protein, was decreased by Ab 25-35 in a dose-dependent manner in WT mice but not in TLR2-KO mice. These results suggest the possibility that TLR2 may play a role in Ab 25-35 -induced synaptic dysfunction.
Microglia play a role in the pathogenesis of AD (Akiyama et al., 2000; Neher et al., 2011; Wyss-Coray, 2006) . In neurons overexpressing amyloid precursor protein, microglia are activated and recruited to Ab deposits (Bolmont et al., 2008; Meyer-Luehmann et al., 2008; Tahara et al., 2006) , and Ab 25-35 causes microgliadependent neuronal loss (Vollmar et al., 2010) . Microglia constitutively express TLR2 (Bsibsi et al., 2002; Hanke and Kielian, 2011; Olson and Miller, 2004) , and TLRs play a role in Ab-induced microglial activation (Chen et al., 2006; Liu et al., 2012; Tahara et al., 2006; Tang et al., 2007) . Ab-triggered inflammatory activation is reduced in TLR2-deficient microglia (Jana et al., 2008) , and TLR2 deficiency reduced Ab-triggered inflammatory activation in cultured microglia, suggesting a beneficial effect of TLR2 inhibition on AD pathogenesis (Liu et al., 2012) . Our data showed that Ab 25-35 induced the expression of Iba-1 and resulted in a more activated morphology in the cultured slices of WT mice compared to that in TLR2-KO mice. And increased Iba-1 immunoreactivity in WT mice was highly colocalized with TLR2 expression, suggesting that Ab 25-35 induced the activation of microglia through TLR2.
Taking these results together, we conclude that TLR2 may play a role in Ab 25-35 -induced neuronal cell loss and synaptic dysfunction through the activation of microglia in OHSCs.
